This document summarizes the state of policy development in the EU to manage contaminants of emerging concern (CECs). It discusses the EU's chemicals legislation and monitoring efforts for CECs in surface water and groundwater. The EU is developing watch lists of substances of concern for surface and groundwater. It is also exploring effect-based monitoring methods and using grouping approaches to assess chemical risks. The document notes efforts to increase data access and sharing, as well as increasing focus on persistent and mobile substances with potential for groundwater contamination. It concludes by mentioning the upcoming EU strategic approach on pharmaceuticals in the environment.
VIP Call Girls Service Bandlaguda Hyderabad Call +91-8250192130
Managing CECs in the EU: State of Play on Policy Development
1. State of play on policy
development to manage
CECs in the EU
Peter Korytár
European Commission, DG Environment, Sustainable chemicals
5 February 2018, OECD, Paris
6. Monitoring of CECs
• Watch lists – ground water – draft prioritisation methodology
All substances
Presence in ground
water
Theoretical groundwater
leaching potential and
extent of potential
environmental exposure
Substances with ground water leaching potential
Toxicological or eco-toxicological
hazard
Groundwater Watch List
8. Monitoring of CECs
• Watch lists – ground water – PFCs detected
Country Monitored Findings
Belgium Yes Yes
Switzerland Yes Yes
Czech Republic Yes ?
France Yes Yes
Italy Yes Yes
Netherlands Yes Yes
Austria Yes Yes
Germany Yes Yes
Sweden Yes Yes
Finland Yes Yes
UK Yes Yes
9. Monitoring of CECs
• Watch lists
• Surface water
• Ground water
European Raptor
Biomonitoring Facility
• Research funding
• More exploratory monitoring is needed
10. Facilitating access to data
• Occurrence data – Information platform for chemical
monitoring (IPCHEM)
Access point for discovering,
accessing and retrieving chemical
occurrence in various media across
the world
11. Facilitating access to data
• Lack of data:
• use and production volumes of chemicals
• ecotox data
• problems with access of data
• Occurrence data – Information platform for chemical
monitoring (IPCHEM)
• Hazard (ecotox) data – in REACH, PPPR and BPR + CLP
• Research data – burdensome to get
12. Exploring effect-based methods
• The monitoring of individual chemicals might be
complemented or partly replaced by the monitoring of effects
or markers of effects using effect-based methods
• Overall – aim to obtain a more holistic picture of water
quality, taking into account more substances without
significantly increasing monitoring effort
• Exploratory work under the common implementation
strategy for the WFD
• NB – need to be able to identify problem substances/sources
to be able to take measures
13. Using grouping approaches
• Using grouping approaches to prevent
existence of CECs or to avoid
regrettable substitution
• PCBs, dioxins, PFOS substances, PBDEs,
PAHs,
• PFAS, macrolide antibiotics,
neonicotinoids
• CMRs, PBTs, vPvBs, EDs
• Using more predictive assessments
(QSARs, etc) and try to assess
substances in groups (whether based
on toxicity or on use)
ECETOC
14. Increasing attention to persistent and
mobile substances
• Development of a new hazard class to classify/identify
substances having potential for groundwater contamination :
• Persistent (Half-life) and Mobile (Solubility in water and Log
Koc)
• Provisional screening of substance (DK EPA + DE UBA)
• 2095 substances included in the analysis using DK QSAR DB
• P: similar to PBTs; M: Sw > 0.15 mg/L and log Koc < 4.5; T: CMR,
STOT RE, classification for effects on or via lactation, DNEL < 9
ug/kg bw/d
• 3-18% fulfilled the PM screening criteria
• 0.2-3.4% fufilled the PMT screening criteria
15. Pharmaceuticals in the environment
• EU strategic approach to pharmaceuticals in the environment
• to be adopted by end May 2018
• possible policy options (not an exclusive list)
• covering whole life-cycle of pharma
• covering all environmental media
• Public consultation still open until 21 Feb
https://ec.europa.eu/info/consultations/public-consultation-
pharmaceuticals-environment_en
16. Pharmaceuticals in the environment
4. Promoting
greener
manufacturing
processes
3. Ensuring the
scientific
robustness,
consistency and
transparency of risk
assessments